Efficacy of galcanezumab in patients with migraine and history of failure to 3 –4 preventive medication categories: subgroup analysis from CONQUER study

ConclusionsGalcanezumab was effective in a difficult-to-treat population of patients with CM or EM who had failed 3 –4 prior preventive medication categories.Trial registrationCONQUER. Clinicaltrials.gov identifier:NCT03559257.

http://link.springer.com/10.1186/s10194-021-01322-7

Source: The Journal of Headache and Pain - September 30, 2021 Category: Neurology Source Type: research